Difference between revisions of "Insulin"
m |
m |
||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Insulin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 12:25, 30 August 2007
| Template:Infobox header| Insulin | |
|---|---|
| |
| Substrate peptide name | Insulin |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P08865 |
| Reactive glutamines | chain A - Q5, Q15 |
| Reactive lysines | - |
| Substrate sequence | chain A - GIVEQC*C*ASVC*SLYQLENYC*N
chain B - FVNQHLC*GS |
| Structure | 1BEN |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:14342319 |
| Notes | * the Cys residues are oxidized |
| Template:Infobox header | | |
